ReviewNutrients2026
Gut Microbiota-Mediated Modulation of Intestinal Serotonin by Tea Polyphenols: Potential Mechanisms and Implications for Metabolic Health.
Review in Nutrients, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Tea polyphenols (TPs), the primary bioactive components derived from tea, play an important role in maintaining gut function and metabolic homeostasis. Emerging evidence indicates that the regulatory functions of TP within the intestine are intricately linked to their interactions with the gut microbiota. Serotonin (5-hydroxytryptamine, 5-HT), a key signaling molecule in the gastrointestinal tract, has been implicated in preserving intestinal function and metabolic health. Notably, the modulation of gut microbiota by TPs, the microbial biotransformation of TPs into bioactive metabolites, and the potential regulation on intestinal 5-HT homeostasis may collectively constitute an interconnected axis relevant to gut health and metabolic balance. However, direct experimental evidence linking these components into a unified mechanistic pathway remains limited, and the molecular basis of this putative TP-microbiota-5-HT axis requires further validation. This review systematically summarizes and discusses the regulatory effects of TPs on gut microbiota, and the microbial biotransformation of TPs into metabolites, as well as the microbial modulation of intestinal 5-HT and the roles of 5-HT and its receptors in intestinal function and homeostasis, with a particular focus on critically evaluating the extent to which current data support the proposed interactions among TPs, gut microbiota, and 5-HT in metabolic disorders. A deeper understanding of this tripartite interaction may ultimately inform the development of TP-based dietary approaches targeting gut microbiota-5-HT interactions in gut function and metabolic health, although such translational applications remain speculative in the absence of robust causal evidence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.